Müzeyyen Gönül

Müzeyyen Gönül

Auto-generated profile, based on publicly available information

Müzeyyen Gönül

Department of Dermatology & Venereology, Ankara Etlik City Hospital

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2016 in Dermatology Research and Practice
Verified
Journal Article
Open access
PDF file
BGBilgen Gençler
Bilgen Gençler
MGMüzeyyen Gönül
Müzeyyen Gönül
The incidence of melanoma has recently been increasing. BRAF mutations have been found in 40–60% of melanomas. The increased activity of BRAF V600E leads to the activation of downstream signaling through the mitogen-activated protein kinase (MAPK) pathway, which plays a key role as a regulator of cell growth, differentiation, and survival. The use of BRAF inhibitors in metastatic melanoma with BRAF mutation ensures clinical improvement of the disease. Vemurafenib and dabrafenib are two selective BRAF inhibitors approved by the Food and Drug Administration (FDA). Both drugs are well tolerated and successfully used in clinical practice. However, some adverse reactions have been reported in patients in the course of treatment. Cutaneous side effects are the most common adverse events among them with a broad spectrum. Both the case reports and several original clinical trials reported cutaneous reactions during the treatment with BRAF inhibitors. In this review, the common cutaneous side effects of BRAF inhibitors in the treatment of metastatic melanoma with BRAF V600E mutation were reviewed.

1 October 2018 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
MGMuzeyyen Gonul
Muzeyyen Gonul
BCBengu Cevirgen Cemil
Bengu Cevirgen Cemil
HAHavva Hilal Ayvaz
Havva Hilal Ayvaz
ECEylem Cankurtaran
Eylem Cankurtaran
CECan Ergin
Can Ergin
MGMehmet Salih Gurel
Mehmet Salih Gurel
Keywords: Alopecia; Alopecia areata; Female; Male; Quality of life

1 January 2016 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
BCBengu Cevirgen Cemil
Bengu Cevirgen Cemil
HAHavva Hilal Ayvaz
Havva Hilal Ayvaz
GOGulfer Ozturk
Gulfer Ozturk
CECan Ergin
Can Ergin
HAHavva Kaya Akıs
Havva Kaya Akıs
EAErcan Arzuhal
Ercan Arzuhal
Introduction : Isotretinoin has been successfully used for the treatment of acne vulgaris. Aim : To investigate the effects of isotretinoin on body mass index (BMI), to determine whether isotretinoin causes any changes in serum adiponectin, leptin, and ghrelin levels in acne vulgaris...

28 August 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MGMüzeyyen Gönül
Müzeyyen Gönül
BCBengu Cevirgen Cemil
Bengu Cevirgen Cemil
HKHavva Ozge Keseroglu
Havva Ozge Keseroglu
HAHavva Kaya Akis
Havva Kaya Akis
Many advances in dermatology have been made in recent years. In the present review article, newly described disorders from the last six years are presented in detail. We divided these reports into different sections, including syndromes, autoinflammatory diseases, tumors, and unclassified disease. Syndromes included are “circumferential skin creases Kunze type” and “unusual type of pachyonychia congenita or a new syndrome”; autoinflammatory diseases include “chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome,” “pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome,” and “pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH) syndrome”; tumors include “acquired reactive digital fibroma,” “onychocytic matricoma and onychocytic carcinoma,” “infundibulocystic nail bed squamous cell carcinoma,” and “acral histiocytic nodules”; unclassified disorders include “saurian papulosis,” “symmetrical acrokeratoderma,” “confetti-like macular atrophy,” and “skin spicules,” “erythema papulosa semicircularis recidivans.”

1 January 2007 in Journal of Asthma
Verified
Journal Article
Closed access
ÜGÜlker Gül
Ülker Gül
SÇSeray Külcü Çakmak
Seray Külcü Çakmak
IOIşil Olcay
Işil Olcay
AKArzu Kılıç
Arzu Kılıç
MGMüzeyyen Gönül
Müzeyyen Gönül
Nickel sulphate frequently causes allergic contact dermatitis; less known effects are nasal inflammation (rhinitis) and bronchial asthma. In this study, we aimed to find if there is a relationship between asthma and nickel sensitivity. Asthmatic patient, non-asthmatic atopic, and healthy control groups were patch tested with nickel sulphate. Nickel sensitivity was more prevalent in the asthmatic patient group compared to the non-asthmatic atopic and healthy control groups.

17 January 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
HAHati̇cE Ataş
Hati̇cE Ataş
MGMüzeyyen Gönül
Müzeyyen Gönül
YÖYasi̇n Öztürk
Yasi̇n Öztürk
MKMustafa Kavutçu
Mustafa Kavutçu
Background and aim: The results show that oxidative stress is a pathophysiologic factor for alopecia areata (AA); however, the markers used can be confounding. Thus, we aimed to investigate the role of oxidative stress in the pathogenesis of AA through an evaluation of ischemia-modified albumin (IMA), other markers of the oxidant/antioxidant system; such as SOD, CAT, GSH-ST and MDA, and contributing clinical risk factors. Materials and Methods: The usefulness of IMA as a new marker for oxidative stress was compared with other markers, and evaluated in patients with AA. Results: The mean serum level of IMA was of higher statistical significance in AA patients than in the control group (IMA: 0.57±0.01 vs. 0.52±0.02 ΔABSU, p1 site involvement of disease and increased severity of disease were correlated with increased oxidation. Presence of AA, male gender and severe disease were determined to be independent risk factors for antioxidant and oxidant systems. IMA has great potential as a biomarker of oxidative stress in AA when compared to other studied biomarkers. Keywords: biomarkers, alopecia areata, oxidative stress, antioxidative system, ischemia-modified albumin